ABIOMED

ABMD (US0036541003)

Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. 

Market: Nasdaq

Fair value: $116

Discount: N/A

Average yearly return: 55%
Yield: N/A

Outperformer

ABMD announced that on Thursday, July 28, 2016, the Company will
release financial results for the first quarter of fiscal 2017. The Company
will host a conference call to discuss the results on Thursday, July 28, 2016,
at 8:00 a.m. EDT.